A comparative study between Pericapsular nerve group block and femoral nerve blockusing ropivacaine 0.2% 25ml for ease of positioning to central neuraxial block in HIPsurgeries
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 78
- Locations
- 1
- Primary Endpoint
- 1.Efficacy of PENG block
Study Overview
Brief Summary
PURPOSE : A comparative study between Pericapsular nerve group block and Femoral nerve block using 25ml of 0.2% Ropivacaine for ease of positioning to central neuraxial block for Hip surgeries.
DESIGN : RANDOMIZED,CONTROLLED TRAIL
PARTICIPANT AND CONTROL : Patients undergoing Hip surgeries will be Randomly allocated to one of the two groups based on computer generated random number.
INTERVENTION : Site of injection is marked, under strict aseptic precautions and USG guided 25ml Local anaesthetic agent is administered after negative aspiration.
Inj. Ropivacaine 0.2% 25ml is administered in incremental dose after negative aspiration for every 5ml using 22G Spinal needle or 10cm stimiplex block needle.
Group P will receive 25mls of 0.2% Ropivacaine for pericapsular nerve group block
Group F will receive 25mll of 0.2% Ropivacaine for femoral nerve block
Vitals and VAS score is monitored from time of injection till position for central neuraxial block.
Pain Score and Angle of sitting position to administer central neuraxial block is noted.
MAIN OUTCOME MEASURES : Efficacy of Pericapsular nerve group block for positioning of patient for central neuraxial block
Study Design
- Study Type
- Interventional
- Allocation
- Computer generated randomization
- Masking
- Participant, Investigator and Outcome Assessor Blinded
Eligibility Criteria
- Ages
- 50.00 Year(s) to 90.00 Year(s) (—)
- Sex
- Male
Inclusion Criteria
- •Patients of either sex, 2) 50–90 years of age, 3) American Society of Anesthesiologists (ASA) physical grading I–III were included in the study.
Exclusion Criteria
- •Exclusion criteria included patient refusal to participate in the study, 2) Presence of any coagulation disorders, 3) Presence of multiple fractures, 4) Any patients with head injury or other injuries,.
Outcomes
Primary Outcomes
1.Efficacy of PENG block
Time Frame: 40mins
2.Ease of positioning for central neuraxial block
Time Frame: 40mins
Secondary Outcomes
- not applicable(not applicable)